Privileged Scaffolds for Drug Design and Activity Improvement-Part I

Yongtao       Duan; Hai-liang       Zhu

doi:10.2174/156802662028201021110151

[1] 
Huang, H.; Song, C.; Chang, J. Synthesis and biological activity study of tanshinone derivatives: a literature and patent review. Curr. Top. Med. Chem.,  2020, 20(28), 2520-2534.
[2] 
Zhang, Z.; Shu, B.; Zhang, Y.; Deora, G.S.; Li, Q-S. 2,4,5-Trisubstituted thiazole: a privileged scaffold in drug design and activity improvement. Curr. Top. Med. Chem.,  2020, 20(28), 2535-2577.
[3] 
Xu, C.; Fang, M-Y.; Wang, K.; Liu, J.; Tai, G-P.; Zhang, Z-T.; Ruan, B-F. Discovery and development of inflammatory inhibitors from 2-phenylchromonone (flavone) scaffolds. Curr. Top. Med. Chem.,  2020, 20(28), 2578-2598.
[4] 
Mao, Y.; Soni, K.; Sangani, C.; Yao, Y. An overview of privileged scaffold: quinolines and isoquinolines in medicinal chemistry as anticancer agents. Curr. Top. Med. Chem.,  2020, 20(28), 2599-2633.
[5] 
Li, D-D.; Yu, P.; Xiao, W.; Wang, Z-Z.; Zhao, L-G. Berberine: a promising natural isoquinoline alkaloid for development of hypolipidemic drug. Curr. Top. Med. Chem.,  2020, 20(28), 2634-2647.

Rights & Permissions Print Cite

Article Metrics

9

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/156802662028201021110151	Print ISSN 1568-0266
Publisher Name Bentham Science Publisher	Online ISSN 1873-4294

Current Topics in Medicinal Chemistry

Privileged Scaffolds for Drug Design and Activity Improvement-Part I

Related Journals

Related Books